← FDA DRUG APPROVALS

FDA ANDA · ANDA206581

IBUPROFEN SODIUM

Sponsor: PERRIGO R AND D

APPLICATION
ANDA206581
TYPE
ANDA
ORIGINAL APPROVAL
2015-08-03
LATEST ACTION
2016-02-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

IBUPROFEN SODIUMDiscontinued
IBUPROFEN SODIUM EQ 200MG BASE · TABLET · ORAL

Approval history

2016-02-19Manufacturing (CMC) · Supplement 1 · unknownAP
2015-08-03UNKNOWN · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →